Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
107.50
-0.50 (-0.46%)
Apr 20, 2026, 1:24 PM CST

TPE:6919 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,539784.446,9013,422655.05594.91
Short-Term Investments
2,3504,0762,767289.4456.18-
Cash & Short-Term Investments
4,8894,8609,6693,7121,111594.91
Cash Growth
-48.81%-49.73%160.51%234.01%86.79%535.87%
Accounts Receivable
0.426.495.187.893.12-
Receivables
0.426.495.187.893.12-
Inventory
3.482.882.861.022.810.05
Other Current Assets
136.22121.5529.1223.1614.8710.32
Total Current Assets
5,0294,9919,7063,7441,132605.27
Property, Plant & Equipment
44.4750.7761.3280.4199.6106.38
Long-Term Investments
4,4424,425----
Other Long-Term Assets
20.887.713.142.461.461.26
Total Assets
9,5379,4749,7713,8271,233712.9
Accounts Payable
0.591.260.971.72.530.33
Accrued Expenses
10.135.051.97--30.98
Current Portion of Long-Term Debt
-----1.17
Current Portion of Leases
0.7538.888.588.227.03
Current Unearned Revenue
8.451.073.611.034.5-
Other Current Liabilities
91.3335.1137.3262.3733.110.16
Total Current Liabilities
111.2545.4952.7473.6848.3639.67
Long-Term Debt
-----3.55
Long-Term Leases
--311.8720.4625.02
Pension & Post-Retirement Benefits
0.520.480.24---
Other Long-Term Liabilities
62.0217.6817.71---
Total Liabilities
173.7963.6673.785.5568.8268.24
Common Stock
778.63776.94769.14696.62615.55535.93
Additional Paid-In Capital
9,2688,7539,1313,271834.46217.47
Retained Earnings
-27.7180.04-56.14-227.31-286.16-107.41
Treasury Stock
-130.52-130.52--0.07-0.08-0.09
Comprehensive Income & Other
-525.36-68.54-147.470.810.49-1.24
Shareholders' Equity
9,3639,4109,6973,7411,164644.66
Total Liabilities & Equity
9,5379,4749,7713,8271,233712.9
Total Debt
0.75311.8720.4628.6836.78
Net Cash (Debt)
4,8884,8579,6573,6911,083558.13
Net Cash Growth
-48.77%-49.70%161.63%240.96%93.96%-
Net Cash Per Share
3.163.156.752.980.920.61
Filing Date Shares Outstanding
1,5561,5531,5381,3931,2311,072
Total Common Shares Outstanding
1,5561,5531,5381,3931,2311,072
Working Capital
4,9184,9469,6533,6701,084565.6
Book Value Per Share
6.026.066.302.690.950.60
Tangible Book Value
9,3639,4109,6973,7411,164644.66
Tangible Book Value Per Share
6.026.066.302.690.950.60
Machinery
149.23149.23138.75129.99121.55112.76
Construction In Progress
3.892.37-1.141.820.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.